SCHEMBL28067644

SCHEMBL28067644

[CH2]c1ccc([N+](=O)[O-])cc1C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
ALDH1A1 P00352 7/20 0.44
PGR P06401 1/20 0.43
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
LMNA P02545 2/20 0.39
HTT P42858 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
KDM4E B2RXH2 1/20 0.39
P2RX4 Q99571 1/20 0.39
P2RX7 Q99572 1/20 0.39
P2RX2 Q9UBL9 1/20 0.39
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
CHRNB4 P30926 2/20 0.38
CHRNA3 P32297 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6363105 0.78 ALDH1A1 (0.50) NPC1RAB9AL3MBTL1ALDH1A1MEN1
SCHEMBL18992722 0.74 NPC1 (0.69) NPC1RAB9AL3MBTL1ALDH1A1PGR
SCHEMBL3190249 0.71 NPC1 (0.45) NPC1RAB9AL3MBTL1ALDH1A1PGR
SCHEMBL28015555 0.70 ALDH1A1 (0.44) NPC1RAB9AALDH1A1PGRMEN1
SCHEMBL16049433 0.70 HSPB1 (0.46) NPC1RAB9AALDH1A1PGRMEN1
SCHEMBL6234527 0.68 NPC1 (0.47) NPC1RAB9AALDH1A1PGRMEN1
SCHEMBL3250886 0.68 ALDH1A1 (0.39) NPC1RAB9AALDH1A1MEN1KMT2A
SCHEMBL15071010 0.67 RAB9A (0.59) NPC1RAB9AL3MBTL1ALDH1A1PGR
SCHEMBL27892542 0.66 HSP90AA1 (0.55) ALDH1A1LMNATDP1CHRNB4CHRNA3
SCHEMBL232696 0.65 TDP1 (0.61) ALDH1A1MEN1KMT2ALMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105612172-A Cyclic polypeptides for the treatment of heart failure NOVARTIS AG 2016-05-25 CN disclosed